Implandata Ophthalmic Products GmbH, a Hanover, Germany-based start-up developing a new kind of diagnosis tool for glaucoma therapy, has raised about €700,000.
The funds, which come from High-Tech Gründerfonds, hannover innovation fonds (hif), a Munich ophthalmologist as private investor as well as the two founders, will be used to launch the company’s system for continuously monitoring the intraocular pressure of glaucoma patients.
This tool enables specialists to recognise the disease and to protect the patients against blindness. It can even be used telemedically.
After having proven the system’s functionality and safety in-vitro and in-vivo on animals and humans, the company will use the new capital to obtain CE approval and go to market by the end of 2011.